Proteomic analysis and immunogenicity of Mannheimia haemolytica vesicles

Clinical and Vaccine Immunology

Volumn 20, Issue 2, 2013, Pages 191-196

  Ayalew, Sahlu ^a   Confer, Anthony W ^a   Shrestha, Binu ^b   Wilson, Amanda E ^a   Montelongo, Marie ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; LEUKOTOXIN; LEUKOTOXIN ANTIBODY; MANNHEIMIA HAEMOLYTICA ANTIBODY; MANNHEIMIA HAEMOLYTICA VACCINE; OUTER MEMBRANE PROTEIN; TOXIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIUM IDENTIFICATION; BAGG ALBINO MOUSE; CATTLE DISEASE; CONTROLLED STUDY; CYTOPLASM; DAIRY CATTLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; IMMUNOGENICITY; LIQUID CHROMATOGRAPHY; LUNG LESION; MANNHEIMIA HAEMOLYTICA; MOUSE; NONHUMAN; PNEUMONIC PASTEURELLOSIS; PRIORITY JOURNAL; PROTEOMICS; SCORING SYSTEM; TANDEM MASS SPECTROMETRY; WHOLE CELL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; CYTOPLASMIC VESICLES; MANNHEIMIA HAEMOLYTICA; MICE; MICE, INBRED BALB C; PASTEURELLACEAE INFECTIONS; VACCINATION;

EID: 84874911928     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00622-12     Document Type: Article

References (49)

1. Panciera RJ, Confer AW. 2010. Pathogenesis and pathology of bovine pneumonia. Vet. Clin. North Am. Food Anim. Pract. 26:191-214.
2. Perino LJ, Hunsaker BD. 1997. A review of bovine respiratory disease vaccine field efficacy. Bovine Practitioner 31:59-66.
3. Confer AW. 1993. Immunogens of Pasteurella. Vet. Microbiol. 37:353-368.
4. Ayalew S, Confer AW, Hartson SD, Shrestha B. 2010. Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates. Proteomics 10:2151-2164.
5. Ayalew S, Shrestha B, Montelongo M, Wilson A, Confer AW. 27 August 2011. Identification and immunogenicity of Mannheimia haemolytica S1 outer membrane lipoprotein PlpF. Vaccine [Epub ahead of print.] doi: 10.1016/j.vaccine.2011.08. 074.
6. Ayalew S, Shrestha B, Montelongo M, Wilson AE, Confer AW. 2011. Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15. Clin. Vaccine Immunol. 18:2067-2074.
7. Confer AW, Ayalew S, Montelongo M, Step DL, Wray JH, Hansen RD, Panciera RJ. 2009. Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein. Vaccine 27:1771-1776.
8. Confer AW, Ayalew S, Panciera RJ, Montelongo M, Whitworth LC, Hammer JD. 2003. Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine. Vaccine 21:2821-2829.
9. Confer AW, Ayalew S, Panciera RJ, Montelongo M, Wray JH. 2006. Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge. Vaccine 24:2248-2255.
10. Pandher K, Confer AW, Murphy GL. 1998. Genetic and immunologic analyses of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica serotype 1. Infect. Immun. 66:5613-5619.
11. Ayalew S, Confer AW, Payton ME, Garrels KD, Shrestha B, Ingram KR, Montelongo MA, Taylor JD. 2008. Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin. Vaccine 26:4955-4961.
12. Shewen PE, Wilkie BN. 1988. Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica. Can. J. Vet. Res. 52:30-36.
13. Kato S, Kowashi Y, Demuth DR. 2002. Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb. Pathog. 32:1-13.
14. Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ. 2004. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 23:4538-4549.
15. Nieves W, Asakrah S, Qazi O, Brown KA, Kurtz J, Aucoin DP, McLachlan JB, Roy CJ, Morici LA. 2011. A naturally derived outermembrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine 29:8381-8389.
16. Kuehn MJ, Kesty NC. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19:2645-2655.
17. Park SB, Jang HB, Nho SW, Cha IS, Hikima J, Ohtani M, Aoki T, Jung TS. 2011. Outer membrane vesicles as a candidate vaccine against edwardsiellosis. PLoS One 6:e17629. doi:10.1371/journal.pone.0017629.
18. Koeberling O, Seubert A, Santos G, Colaprico A, Ugozzoli M, Donnelly J, Granoff DM. 2011. Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys. Vaccine 29:4728-4734.
19. Sanders H, Feavers IM. 2011. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Rev. Vaccines 10:323-334.
20. Murphy GL, Whitworth LC, Clinkenbeard KD, Clinkenbeard PA. 1995. Hemolytic activity of the Pasteurella haemolytica leukotoxin. Infect. Immun. 63:3209-3212.
21. Kwon SO, Gho YS, Lee JC, Kim SI. 2009. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol. Lett. 297:150-156.
22. Horstman AL, Kuehn MJ. 2000. Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J. Biol. Chem. 275:12489-12496.
23. Petrie A, Watson P. 1999. Statistics for veterinary and animal science. Blackwell Press, London, United Kingdom.
24. Burciaga-Robles LO, Krehbiel CR, Step DL, Holland BP, Richards CJ, Montelongo MA, Confer AW, Fulton RW. 2010. Effects of exposure to calves persistently infected with bovine viral diarrhea virus type 1b and Mannheimia haemolytica challenge on animal performance, nitrogen balance, and visceral organ mass in beef steers. J. Anim. Sci. 88:2179-2188.
25. Ayalew S, Step DL, Montelongo M, Confer AW. 2009. Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B. Vet. Immunol. Immunopathol. 132:295-302.
26. Ayalew S, Confer AW, Blackwood ER. 2004. Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE. Infect. Immun. 72: 7265-7274.
27. Frey A, Di Canzio J, Zurakowski D. 1998. A statistically defined endpoint titer determination method for immunoassays. J. Immunol. Methods 221: 35-41.
28. Beveridge TJ. 1999. Structures of gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181:4725-4733.
29. Miller SI, Bader M, Guina T. 2003. Bacterial vesicle formation as a mechanism of protein transfer to animals. Cell 115:2-3.
30. Bishop AL, Tarique AA, Patimalla B, Calderwood SB, Qadri F, Camilli A. 2012. Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission. J. Infect. Dis. 205:412-421.
31. Nakao R, Hasegawa H, Ochiai K, Takashiba S, Ainai A, Ohnishi M, Watanabe H, Senpuku H. 2011. Outer membrane vesicles of Porphyromonas gingivalis elicit a mucosal immune response. PLoS One 6:e26163. doi:10.1371/journal.pone.0026163.
32. Toneatto D, Ismaili S, Ypma E, Vienken K, Oster P, Dull P. 2011. The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans. Hum. Vaccines 7:646-653.
33. Roy K, Hamilton DJ, Munson GP, Fleckenstein JM. 2011. Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli. Clin. Vaccine Immunol. 18:1803-1808.
34. Chen DJ, Osterrieder N, Metzger SM, Buckles E, Doody AM, DeLisa MP, Putnam D. 2010. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc. Natl. Acad. Sci. U. S. A. 107:3099-3104.
35. Jeannin P, Magistrelli G, Goetsch L, Haeuw JF, Thieblemont N, Bonnefoy JY, Delneste Y. 2002. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine 20(Suppl. 4):A23-A27.
36. Aghasadeghi MR, Salmani AS, Sadat SM, Javadi F, Memarnejadian A, Vahabpour R, Zabihollahi R, Moshiri A, Siadat SD. 2011. Application of outer membrane vesicle of Neisseria meningitidis serogroup B as a new adjuvant to induce strongly Th1-oriented responses against HIV-1. Curr. HIV Res. 9:630-635.
37. Haneberg B, Dalseg R, Oftung F, Wedege E, Hoiby EA, Haugen IL, Holst J, Andersen SR, Aase A, Meyer Naess L, Michaelsen TE, Namork E, Haaheim LR. 1998. Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant. Dev. Biol. Stand. 92:127-133.
38. Fukasawa LO, Dias WO, Schenkman RP, Raw I, Tanizaki MM. 2004. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice. FEMS Immunol. Med. Microbiol. 41:205-210.
39. Shewen PE, Lee CW, Perets A, Hodgins DC, Baldwin K, Lo RY. 2003. Efficacy of recombinant sialoglycoprotease in protection of cattle against pneumonic challenge with Mannheimia (Pasteurella) haemolytica A1. Vaccine 21:1901-1906.
40. Briggs RE, Tabatabai LB, Tatum FM. 2012. Mucosal and parenteral vaccination against pneumonic pasteurellosis in cattle with a modifiedlive in-frame lktA deletion mutant of Mannheimia haemolytica. Microb. Pathog. 52:302-309.
41. Crouch CF, LaFleur R, Ramage C, Reddick D, Murray J, Donachie W, Francis MJ. 2012. Cross protection of a Mannheimia haemolytica A1 Lkt-/Pasteurella multocida DeltahyaE bovine respiratory disease vaccine against experimental challenge with Mannheimia haemolytica A6 in calves. Vaccine 30:2320-2328.
42. Panciera RJ, Corstvet RE. 1984. Bovine pneumonic pasteurellosis: model for Pasteurella haemolytica- and Pasteurella multocida-induced pneumonia in cattle. Am. J. Vet. Res. 45:2532-2537.
43. Friend SC, Wilkie BN, Thomson RG, Barnum DA. 1977. Bovine pneumonic pasteurellosis: experimental induction in vaccinated and nonvaccinated calves. Can. J. Comp. Med. 41:77-83.
44. Friend SC, Thomson RG, Wilkie BN. 1977. Pulmonary lesions induced by Pasteurella hemolytica in cattle. Can. J. Comp. Med. 41:219-223.
45. Wildman BK, Perrett T, Abutarbush SM, Guichon PT, Pittman TJ, Booker CW, Schunicht OC, Fenton RK, Jim GK. 2008. A comparison of 2 vaccination programs in feedlot calves at ultra-high risk of developing undifferentiated fever/bovine respiratory disease. Can. Vet. J. 49:463-472.
46. Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W. 2012. BALB/c mice, but not C57BL/6 mice immunized with a DeltaclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses. Vaccine 30: 3634-3645.
47. Rice PA, McQuillen DP, Gulati S, Jani DB, Wetzler LM, Blake MS, Gotschlich EC. 1994. Serum resistance of Neisseria gonorrhoeae. Does it thwart the inflammatory response and facilitate the transmission of infection? Ann. N. Y. Acad. Sci. 730:7-14.
48. Ray TD, Lewis LA, Gulati S, Rice PA, Ram S. 2011. Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H. 8 and Laz lipoproteins. J. Immunol. 186:4881-4894.
49. Keller A, Purvine S, Nesvizhskii AI, Stolyar S, Goodlett DR, Kolker E. 2002. Experimental protein mixture for validating tandem mass spectral analysis. OMICS 6:207-212.